Literature DB >> 6610685

Ia+ T cells in new onset Graves' disease.

R A Jackson, B F Haynes, W M Burch, K Shimizu, M A Bowring, G S Eisenbarth.   

Abstract

The Ia (immune-associated, DR) antigen is a cell surface glycoprotein which is absent on normal circulating T lymphocytes but present on activated T lymphocytes. We studied the expression of this antigen on circulating T lymphocytes from patients with untreated hyperthyroid Graves' disease. All patients (n = 33) with recent onset hyperthyroid Graves' disease studied had an increased percentage and number of circulating Ia+ T cells. Patients with non-Graves's hyperthyroidism or Graves' disease patients more than 1 yr after thyroid ablation had normal values for Ia+ T cells. Other cell surface activation antigens, recognized by monoclonal antibodies 4F2 and 5E9, were not present on circulating T cells in patients with Graves' disease. The 100% positivity for increased numbers of Ia antigen-bearing T cells in hyperthyroid Graves' disease contrasts with our finding of 70% positivity in another HLA-DR-associated disease, recent onset type I diabetes mellitus. The pathogenic significance of these cells is not known, but they seem to represent selective activation of the immune system in patients with untreated hyperthyroid Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610685     DOI: 10.1210/jcem-59-2-187

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 2.  Delineating the autoimmune mechanisms in Graves' disease.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients.

Authors:  U Di Mario; F P Cavatorta; R Perfetti; G Pugliese; P Pozzilli; J Sutherland; M Vitillo; D Andreani
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

4.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

5.  HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis.

Authors:  S Fredrikson; A Karlsson-Parra; T Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

6.  Is insulin-dependent diabetes mellitus an autoimmune disorder?

Authors:  M H Tan; R McManus
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

7.  Sequential psychological testing during the course of autoimmune hyperthyroidism.

Authors:  R Paschke; I Harsch; B Schlote; I Vardarli; L Schaaf; S Kaumeier; J Teuber; K H Usadel
Journal:  Klin Wochenschr       Date:  1990-10-03

8.  Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.

Authors:  R V Lloyd; T L Johnson; M Blaivas; J C Sisson; B S Wilson
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

9.  Activated T cells in Graves' disease before treatment.

Authors:  R Kennedy; U Di Mario; P Pozzilli; K Guy; M Leonardi; M Sensi; D Andreani
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

Review 10.  SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.

Authors:  Avaniyapuram Kannan Murugan; Ali S Alzahrani
Journal:  Endocrine       Date:  2021-06-09       Impact factor: 3.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.